This episode is dedicated to helping pain physicians effectively integrate orthobiologics treatments, also known as regenerative medicine, into their practices. There are a lot of economic considerations as it relates to the patient experience, payer approval, and FDA approval, and here to help us understand this topic is Dr. Nikhil Verma. A board-certified physiatrist and regenerative medicine specialist, Dr. Nikhil joins the show today to discuss the common misconceptions around orthobiologics and what you must be aware of before diving into this form of medicine.
Listen in as he shares the importance of doing your research on trials around orthobiologics before signing up, as well as why a company simply saying that they are “FDA approved” does not necessarily mean that they are reimbursable by insurance. You will learn how to understand the cost of these treatments, who you should be seeing to perform them, and how they work.
What You’ll Learn In Today’s Episode:
- Dr. Nikhil’s background and how he became interested in spine and musculoskeletal health.
- What regenerative medicine is and a common misconception around this topic.
- How much these treatments may cost and whether your insurance will cover any of it.
- The importance of doing your research on trials before signing up.
- How doctors are currently bridging the gap between the beginning stages of pain and surgery.
Ideas Worth Sharing:
“We don’t really regenerate cells. What we do is provide an environment to allow the current cellular structures to grow, to get better support, and to improve the conditions in that area.” – Dr. Nikhil Verma
“The people that should be practicing [orthobiologics] are the pain doctors… they’re seeing where this pain is coming from firsthand.” – Dr. Nikhil Verma
“Pain relief happens over time.” – Dr. Nikhil Verma
Resources In Today’s Episode:
Share The Love:
If you like the Anesthesia & Pain Management Success podcast …